Caleres Reports Lower Q4 Sales, Cautious Outlook For 2025 Amid Inflation And Tariffs Caleres, Inc. (NYSE:CAL) shares are trading higher after the company reported fourth-quarter results. Revenues fell 8.3% year over year to $639.2 million, missing the analyst consensus of $653.86 million. Famous Footwear sales fell 9.6% Y/Y, with comparable store sales down 2.9%. Brand Portfolio sales decreased 7.2% in the quarter. “Famous Footwear’s business softened in the quarter, but we maximized key selling periods. We invested to support our long-term growth while continuing to evolve our supply chain and further mitigate the impact of additional tariffs,” said Jay Schmidt, president and chief executive officer. The company’s gross margin rate contracted 80 basis points year over year to 43.0% and adjusted EBITDA fell to $29.0 million. Adjusted EPS of 33 cents beat the consensus of 24 cents. In 2024, Caleres returned $74.7 million in cash to shareholders through dividends and share repurchases. Borrowings under the revolving credit facility totaled $219.5 million at the end of the period. “As we look forward to 2025 and the macroeconomic environment with persistent inflation and newer tariffs, we believe it is prudent to take a conservative view for the year,” added Schmidt. Outlook: The company expects FY25 net sales to decline by 1% to up 1% and EPS of $2.80 – $3.20 (consensus $3.21). For the first quarter, Caleres expects sales to decline 5% – 6% and EPS of $0.35 – $0.40 vs. consensus of $0.87. Caleres said it currently expects 75% of its Brand Portfolio, and an even greater percentage of Lead Brands’ sourcing to be outside of China by the second half of 2025. Last month, the company inked a deal to acquire Stuart Weitzman from Tapestry for $105 million. The guidance excludes this acquisition, which is expected to close in the summer of 2025. Price Action: CAL shares are down 2.46% at $15.99 at the last check Thursday. Read Next: Temu Parent PDD Holdings Drops After Q4 Revenue Miss: Details Image via Shutterstock. Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Caleres Reports Lower Q4 Sales, Cautious Outlook For 2025 Amid Inflation And Tariffs originally appeared on Benzinga.com © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments
Caleres Reports Lower Q4 Sales, Cautious Outlook For 2025 Amid Inflation And Tariffs
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...